A detailed history of Blue Path Capital Management, LLC transactions in Medtronic PLC stock. As of the latest transaction made, Blue Path Capital Management, LLC holds 4,880 shares of MDT stock, worth $390,400. This represents 0.32% of its overall portfolio holdings.

Number of Shares
4,880
Previous 3,996 22.12%
Holding current value
$390,400
Previous $348 Million 22.23%
% of portfolio
0.32%
Previous 0.3%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

BUY
$82.84 - $88.09 $73,230 - $77,871
884 Added 22.12%
4,880 $425 Million
Q4 2023

Jan 11, 2024

BUY
$69.43 - $83.43 $105,255 - $126,479
1,516 Added 61.13%
3,996 $348 Million
Q3 2023

Oct 25, 2023

BUY
$78.22 - $90.4 $193,985 - $224,192
2,480 New
2,480 $194 Million

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $106B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Blue Path Capital Management, LLC Portfolio

Follow Blue Path Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Path Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blue Path Capital Management, LLC with notifications on news.